Carvedilol produces sustained long-term benefits: Follow-up at 12 years

Congestive Heart Failure

Volumn 15, Issue 1, 2009, Pages 5-8

  Macgregor, John F ^a   Blake Wachter, S ^a   Munger, Mark ^a   Stoddard, Greg ^a   Bristow, Michael R ^b   Gilbert, Edward M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; VASODILATOR AGENT; WARFARIN;

ADULT; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT DURATION;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; CARBAZOLES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPANOLAMINES; PROSPECTIVE STUDIES; QUESTIONNAIRES; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 59349105162     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2008.00038.x     Document Type: Article

References (9)

1. Lombardi WL, Gilbert EM. Carvedilol in the failing heart. Clin Cardiol. 2001; 24 (12): 757-766.
2. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996; 334: 1349-1355.
3. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomized trial. Lancet. 1999; 353: 9-13.
4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999; 353: 2001-2007.
5. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001; 344: 1651-1658.
6. Olsen SL, Gilbert EM, Renlund DG, et al. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double blind randomized study. J Am Coll Cardiol. 1995; 25: 1225-1231.
7. Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: A randomized trial of digoxin versus placebo. N Engl J Med. 1982; 306: 699-705.
8. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Carvedilol or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial. Lancet. 2003; 362 (9377): 7-13.
9. Ho KKL, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation. 1993; 88: 107-115.